Is Lidocaine + Tribenoside registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 5 valid registrations of Lidocaine + Tribenoside, including HAEMOPROCT (5,2 %,%, Rectal ointment, SAR 11.60); PILOCIN (50,20 mg/g,mg/g, Cream, SAR 15.00); PROCTO GLYVENOL (5,2 %,%, Cream, SAR 35.45); PROCTO GLYVENOL (400,40 mg,mg, Suppository, SAR 26.70); RECTACURE (5,2 %,%, Cream, SAR 15.00).

Active substances

Lidocaine + Tribenoside

SFDA 5

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
HAEMOPROCT	5,2 %,%	Rectal ointment · Rectal use	1 Tube	SAR 11.60	Generic · Prescription	Gulf Pharmaceutical Industries (Julphar)	Valid
PILOCIN	50,20 mg/g,mg/g	Cream · Rectal use	1 Tube	SAR 15.00	Generic · Prescription	Jamjoom Pharmaceuticals Factory Company	Valid
PROCTO GLYVENOL	5,2 %,%	Cream · Topical	1 Tube	SAR 35.45	Generic · Prescription	Haleon Schweiz AG	Valid
PROCTO GLYVENOL	400,40 mg,mg	Suppository · Rectal use	1 Blister	SAR 26.70	NCE · Prescription	Haleon Schweiz AG	Valid
RECTACURE	5,2 %,%	Cream · Rectal use	1 Tube	SAR 15.00	Generic · Prescription	Jazeera Pharmaceutical Industries (JPI)	Valid

Indications — CHI Daman Drug Formulary

HEMORRHOIDS

Components

Lidocaine

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.